CEO and CFO of Day One Biopharmaceuticals sold shares on May 1st and 3rd at $17.85-$17.89.
CEO of Day One Biopharmaceuticals, Jeremy Bender, sold 9,154 shares at $17.85 on May 3rd, and previously sold 70,051 shares at $17.88 on May 1st. CFO Charles N. York II sold 52,183 shares at $17.89 on May 1st. Both transactions were disclosed in SEC filings. The company's stock has a 52-week low of $9.67, a 52-week high of $18.07, and a current market cap of $1.50 billion.
May 04, 2024
3 Articles